Kengo Hamamura
Higashi, 8128582, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Therapeutic Strategies Targeting the Kidney-Liver-Immune-Heart Network: Circadian and Mechanosensory Pathways in CKD-Associated Cardiac Injury.
Journal: International journal of molecular sciences
Published: March 13, 2026
Benzbromarone as a Novel Candidate for Preventing Alzheimer's Disease: Evidence From Real-World Data Screening and in Vitro Validation.
Journal: Clinical and translational science
Published: March 03, 2026
A transient, B cell-targeted tolerance switch using nanoparticles loaded with metabolizable AhR agonists for antigen-specific immune regulation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 20, 2025
Gas Chromatography-Mass Spectroscopy (GC-MS) Simultaneous Determination of Limonene, Linalool, and Linalyl Acetate in Rat Plasma Following Transdermal Administration of the Essential Oil of Bergamot Loaded Onto Solid Lipid Nanoparticles (NanoBEO).
Journal: Phytotherapy research : PTR
Published: November 13, 2025
Hericenone C exhibits anti-nociceptive effects through RORα-mediated suppression of TLR4 transcription.
Journal: Frontiers in pharmacology
Published: September 11, 2025
Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment.
Journal: Investigative ophthalmology & visual science
Published: June 17, 2025
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer.
Journal: The Journal of biological chemistry
Published: April 11, 2025
Dopamine receptor D3 affects the expression of Period1 in mouse cells via DRD3-ERK-CREB signaling.
Journal: Biochemical and biophysical research communications
Published: January 31, 2025
Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment.
Journal: International journal of molecular sciences
Published: November 05, 2024
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems.
Journal: Pharmaceutics
Published: August 23, 2024
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65.
Journal: Biochemical and biophysical research communications
Published: April 16, 2024
Last Updated: 09/26/2026